B cell special 150, 488"-4899 14 Barrett, T.B., Shu, G.L., Draves, K.E., Pezzutto, A. and Clark, E.A. <1990! Eur..I. lmnmnol. 20, 1053-1059 15 Callard, R.E., Rigley, K.P., Smith, S.H., Thursr2~, S. and Shields, J.G. 11992)j. !mmunol. 148, 2983-2987 16 Carter, R.H. and Fearon, D.T. (1992) Science 256, 105-107 17 Moore, MD., Cooper, NR., T,~ck, B.E and Nemerow, G.R. (1987) Proc. Natl Acad. Sci. USA 84, 9194-9198 18 Nemerow, G.R., McNaughton, M.E. and Cooper, N.R. ! 19851J. lmmunol. 135, 3068-3073 19 Bohnsack, J.E and Cooper, N.R. (1988) J. lmmunol. 14 I, 2569-2576 20 Carter, R.H., Spycher, M.O., Ng, 'r:C., Hoffman, R. and Fearon, D.T. (1988)j. lmmunol. 141,457--463 21 Tsokos, C.C., Lambris, J.D., Finkelmar,, E._)., Anastassiou, E.D. and June, C.H. (1990)]. Imn:unol. 144, 1640- i 645 22 Hebell, T., Ahearn, J.M. and Fearon, D.T. i 1991 ) ,'- ._ience 254, 102-105 23 Oren, R., Takahashi, S., Doss, C., Levy, R. and Les}: S. / 1990) Moi. Cell. Biol. 10, 4007-4015 24 Andria, M.L., Hsieh, C-L., Or:m, R., Francke, U. and Levy, S. (1991),l. lmmunol. 147 i030-1036 i'.5 Lev.~; S., Nguyen, V.Q., ~ :,,-ha, M.L and Takahashi, S. ~ 1991;J. Biol. Chem. 266, 14597-14602 26 Wright, M.D. and Tomlinson, M.G. bnmunol. Today (in press) 27 Schick, M.R., Nguyen, V.Q. and Le~', S. (1993) J. Immunol. 151, 1918-1925 28 Schick, M.R. and Lev.~,S. (1993)J. lmmunol. 151, 4090-4097 29 Bradbury, L.E., Goldmacher, V.S. and Tedder, T.E (19933 J. lmmunol. 151, 2915-2927 30 Chen, Y.X., Welte, K., Gebhard, D.H. and Evans, R.L. (19°4) J. Immunol. 133, 2496-2501 31 Evans, S.S., Lee, D.B., Han, T., Tomasi, T.B. and Evans, R.L. (1990) Blood 76, 2583-2593 32 Chalupny, N.J., Kanner, S.B., Schieven, G.L. et al, (1993) EMBO]. 12, 2691-2696 33 van Noesel, C.J.M., Lankester, A.C. and van Lier, R.A.W. (1993) bnrnunol. Today 14, 8-11 34 van Noesel, C.J.M., Lankester, A.C., van Schijndel, G.M. and van Lier, R.A.W. (1993) Int. Immunoi. 5, 699-705 35 Songyang, Z., Shoelson, S.E., Chaudhuri, M. et al, (1993) Cell 72, 767-778 36 Tuveson, D.A., Carter, R.H., Soltoff, S.P. and Fearon, D.T. (1993) Science 260, 986-989 37 Songyang, Z., Shoelson, S.E., McGlade, J. et al. (1994) Mol. Cell, BioL 14, 2777-2785 38 Pleiman, C.M., Hertz, W.M. and Cambier, J.C. (!994) Science 263, 1609-1612 39 Matsumoto, A.K., Martin, D.R., Carter, R.H., Klickstein, L.B., Ahearn, J.M. and Fearon, D.T. (1993)J. Exp. Med. 178, 1407-1417 40 Pesando, J.M., Bouchard, L.S. and McMaster, B.E. (1989) ]. Exp. Med. 170, 2159-2164 41 Zhou, L-J., Smith, H.M., Waldschmidt, T.J., Schwarting, R., Daley, J. and Tedder, T.E (1994) Mol. Cell. BioL 14, 3884-3894 42 Robey, E.A., Ramsdell, E, Kioussis, D. etal. (1992) Cell 69, 1089-1096 43 Goodnow, C.C. (1992) Annu. Rev. ImmunoL 10, 489-518 Regulation of lymphocyte activation by the " CD22 cell-surtace molecule Che-Leung Law, Svetlana P. Sidorenko and Edward A. Clark Accessory molecules play an important role in the regulation of lymphocyte activation mediated by the B-cell antigen receptor (BCR). CD22 is one such accessory molecule expressed on B-lineage cells. Here, Che-Leung Law and colleagues review current knowledge on the structure-fimction relationship between CD22 and the BCR, discuss the role of CD22 as a cell-adhesion molecule and suggest models for potential in vivo functions of CD22. The ability of vertebrates to combat foreign antigens relies on the production of lymphocytes expressing clonotypic antigen receptors. Although somatic re- arrangement of the receptor genes allows the gener- ,',lion of antigen receptors with diverse recognition capacities, additional molecules, both on the cell mem- bcane and in the cytosol, are needed to ensure efficient signal transduction and appropriate cellular responses subsequent to the binding of antigens by antigen recep- tors. An array of accessory molecules have been ident- ified on the surface of T and B cells 1. The cytoplasmic © 1994, Elsevier Science Lid tails of these molecules may either: (1) recruit crucial signal transduction molecules into receptor complexes that may amplify the magnitude of the signal transduc- tion cascade, a phenomenon common to other recep- tor-mediated signal transduction pathways; (2) improve the overall avidity of antigen-antigen receptor interac- tions; or (3) lower the threshold of antigen required for signaling, which is especially important under circum- stances when antigen concentrations are limiting. Most accessory molecules also participate in cell adhesion by interacting with specific ligands present on 0167-56991941507.00 1m,nunolory 3"oday 4 4 2 rot. 15 No. 91994